Charles River Laboratories International (CRL) Net Income towards Common Stockholders (2009 - 2026)

Charles River Laboratories International has reported Net Income towards Common Stockholders for 18 years, with the latest figure at -$760000.0 in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 101.45% year-over-year to -$760000.0 in Q2 2026; TTM through Jun 2026 was -$237.7 million, a 243.37% decrease from a year earlier, with the FY2025 full-year figure at -$144.3 million, down 1501.75% from the prior year.
• Net Income towards Common Stockholders was -$760000.0 for Q2 2026 at Charles River Laboratories International, up from -$14.8 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $189.1 million in Q4 2022, with the low at -$276.6 million in Q4 2025.
• Average Net Income towards Common Stockholders over 5 years is $45.4 million, with a median of $78.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders soared 48.94% in 2022, then sank 215.3% in 2024.
• Over 5 years, Net Income towards Common Stockholders stood at $189.1 million in 2022, then retreated by 1.07% to $187.1 million in 2023, then tumbled by 215.3% to -$215.7 million in 2024, then dropped by 28.21% to -$276.6 million in 2025, then jumped by 99.73% to -$760000.0 in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$760000.0 (Q2 2026), -$14.8 million (Q1 2026), and -$276.6 million (Q4 2025), per Business Quant data.